2013 AIChE Annual Meeting
Session: Area Plenary: PD2M Plenary Session
Great challenges and opportunities are emerging across the pharmaceutical industry, regulatory, and academic environments, spanning drug discovery, development and manufacturing, to ensure quality and optimise patient outcomes. This calls for collaborative efforts among disciplines and stakeholders. In this session, leaders and authorities in relevant fields will be invited to present their views on how to address some of the critical issues and point out future directions for implementation. Opportunities pertinent to the chemical engineering discipline will be highlighted.
Chair
Shekhar K. Viswanath, Eli Lilly & Co.
Co-Chair
Joe Hannon, DynoChem Inc